Top Markets
Coin of the day
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rang in aandelen #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Aandeelprijs
$9.13
Marktkapitalisatie
$39.27K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-11.76%
Land
IE
Handel Malin Corporation plc (MLC)

Categorie

P/B-ratio voor Malin Corporation plc (MLC)
P/B-ratio op April 2026 TTM: 0.00
Volgens de meest recente financiële rapporten en aandelenkoers van Malin Corporation plc is de huidige P/B-ratio (TTM) 0.00. Eind 2023 had het bedrijf een P/B-ratio van 0.92.
P/B-ratiohistoriek voor Malin Corporation plc van 2015 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.00 -99.89%
2024 0.85 -7.70%
2023 0.92 4.18%
2022 0.88 -35.57%
2021 1.37 102.96%
2020 0.67 -45.49%
2019 1.23 -13.34%
2018 1.42 -14.42%
2017 1.66 -1.02%
2016 1.68 101.21%
2015 0.84 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.128 347,455.56%
FR
1.7723 196,822.22%
DE
1.1696 129,855.56%
JP
15.9323 1,770,155.56%
US
5.1551 572,688.89%
IN